Article info

Download PDFPDF
Salbutamol increases survival motor neuron (SMN) transcript levels in leucocytes of spinal muscular atrophy (SMA) patients: relevance for clinical trial design
  1. Correspondence to Dr Francesco D Tiziano, Istituto di Genetica Medica, Università Cattolica del Sacro Cuore, Largo Francesco Vito, 1 00168 Roma, Italy; fdtiziano{at}rm.unicatt.it
View Full Text

Citation

Tiziano FD, Lomastro R, Pinto AM, et al
Salbutamol increases survival motor neuron (SMN) transcript levels in leucocytes of spinal muscular atrophy (SMA) patients: relevance for clinical trial design

Publication history

  • Received April 21, 2010
  • Revised June 8, 2010
  • Accepted June 9, 2010
  • First published September 12, 2010.
Online issue publication 
December 29, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.